Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Care Institute Teams with NextBio to Study Genomic Data

NEW YORK (GenomeWeb News) – NextBio said today that the Cancer Care Institute will use its software under a strategic collaboration to interpret genomic data from cancer patients.

Under the partnership, CCI, which has campuses in San Jose and Morgan Hill, Calif., will apply the NextBio software platform to analyze patients' genomic data and streamline the use of that information in the clinic.

CCI "cares for a very diverse group of patients of many different races and ethnicities, so we often see findings and trends that are not captured in the literature," Morteza Dowlatshahi, CCI's medical director, said in a statement.

Dowlatshahi said the software provides an "easy-to-use way to interpret our patients' genomic data to conduct research studies as well as to identify optimal treatments."

Alpana Verma-Alag, head of clinical development at NextBio, said that using tools for handling large-scale data handling technologies enables the company to "meaningfully interpret the molecular data from a person in a short amount of time, which has phenomenal implications for translational research and patient care."

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.